Cell Marker Accordion: interpretable single-cell and spatial omics annotation in health and disease
Authors:
- Emma BusarelloEBEmma Busarello
- Giulia BianconGBGiulia Biancon
- Ilaria CimignoloICIlaria Cimignolo
- Fabio LauriaFabio Lauria
- Christian RamirezCRChristian Ramirez
- Gabriele TomèGTGabriele Tomè
- Marianna CiuffredaMCMarianna Ciuffreda
- Giorgia BucciarelliGBGiorgia Bucciarelli
- Alessandro PilliAPAlessandro Pilli
- Stefano Maria MarinoSMStefano Maria Marino
- Vittorio BontempiVBVittorio Bontempi
Open Access
- 7 July 2025
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-18
Abstract
Single-cell technologies offer a unique opportunity to explore cellular heterogeneity in health and disease. However, reliable identification of cell types and states represents a bottleneck. Available databases and analysis tools employ dissimilar markers, leading to inconsistent annotations and poor interpretability. Furthermore, current tools focus mostly on physiological cell types, limiting their applicability to disease. We present the Cell Marker Accordion, a user-friendly platform providing automatic annotation and unmatched biological interpretation of single-cell populations, based on consistency weighted markers. We validate our approach on multiple single-cell and spatial datasets from different human and murine tissues, improving annotation accuracy in all cases. Moreover, we show that the Cell Marker Accordion can identify disease-critical cells and pathological processes, extracting potential biomarkers in a wide variety of disease contexts. The breadth of these applications elevates the Cell Marker Accordion as a fast, flexible, faithful and standardized tool to annotate and interpret single-cell and spatial populations in studying physiology and disease.Keywords
All Related Versions
This publication has 92 references indexed in Scilit:
- Myelomonocytic and monocytic acute myeloid leukemia demonstrate comparable poor outcomes with venetoclax-based treatment: a monocentric real-world studyAnnals of Hematology, 2024
- Acute myeloid leukemia: 2023 update on diagnosis, risk‐stratification, and managementAmerican Journal of Hematology, 2023
- Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage nichesCell, 2022
- Integrated analysis of multimodal single-cell dataCell, 2021
- m6A RNA Methylation Maintains Hematopoietic Stem Cell Identity and Symmetric CommitmentCell Reports, 2019
- Comprehensive Integration of Single-Cell DataCell, 2019
- Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and ImmunityCell, 2019
- Leukemic stem cells: identification and clinical applicationInternational Journal of Hematology, 2017
- Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications forMRDdetection in multiple myelomaCytometry Part B: Clinical Cytometry, 2015
- Spliceosome mutations involving SRSF2, SF3B1, and U2AF35 in chronic myelomonocytic leukemia: Prevalence, clinical correlates, and prognostic relevanceAmerican Journal of Hematology, 2012